Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $112,529 | 40 | 72.8% |
| Travel and Lodging | $22,364 | 35 | 14.5% |
| Unspecified | $9,021 | 4 | 5.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,749 | 4 | 5.0% |
| Food and Beverage | $2,994 | 38 | 1.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Travere Therapeutics, Inc. | $67,898 | 64 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $28,923 | 19 | $0 (2024) |
| Janssen Research & Development, LLC | $28,492 | 11 | $0 (2022) |
| AbbVie, Inc. | $26,411 | 21 | $0 (2017) |
| Retrophin, Inc. | $1,426 | 3 | $0 (2018) |
| AstraZeneca AB | $1,400 | 2 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $108.32 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,975 | 28 | Novartis Pharmaceuticals Corporation ($28,799) |
| 2023 | $34,162 | 40 | Travere Therapeutics, Inc. ($34,037) |
| 2022 | $13,375 | 3 | Janssen Research & Development, LLC ($13,250) |
| 2021 | $9,150 | 5 | Travere Therapeutics, Inc. ($7,750) |
| 2020 | $22,248 | 12 | Travere Therapeutics, Inc. ($15,810) |
| 2019 | $625.00 | 1 | Janssen Research & Development, LLC ($625.00) |
| 2018 | $9,431 | 10 | Janssen Research & Development, LLC ($7,896) |
| 2017 | $26,693 | 22 | AbbVie, Inc. ($26,411) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,583.00 | General |
| 10/15/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,583.00 | General |
| 10/14/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $118.39 | General |
| 09/20/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $676.96 | General |
| 09/20/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $476.52 | General |
| 09/20/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $405.16 | General |
| 09/06/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $7,850.00 | General |
| 09/06/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $781.63 | General |
| 09/06/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $295.26 | General |
| 09/06/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $175.44 | General |
| 09/06/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $80.00 | General |
| 09/06/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.96 | General |
| 09/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $139.13 | General |
| 07/31/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,725.00 | General |
| 06/18/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,291.50 | General |
| 06/18/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,291.50 | General |
| 06/18/2024 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| 06/18/2024 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| 06/07/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| 06/06/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $7,200.00 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $431.52 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $368.88 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $209.97 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $88.26 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| M11-352 | AbbVie, Inc. | $4,521 | 3 |
About Dr. Donald Kohan, MD
Dr. Donald Kohan, MD is a Nephrology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235229840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Kohan, MD has received a total of $154,658 in payments from pharmaceutical and medical device companies, with $38,975 received in 2024. These payments were reported across 121 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($112,529).
Practice Information
- Specialty Nephrology
- Location Salt Lake City, UT
- Active Since 10/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1235229840
Products in Payments
- INVOKANA (Drug) $8,912
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Salt Lake City
Alfred Cheung, Md, MD
Nephrology — Payments: $169,239
Fuad Shihab, Md, MD
Nephrology — Payments: $133,104
Srinivasan Beddhu, Md, MD
Nephrology — Payments: $8,338
Gopal Chemiti, Md, MD
Nephrology — Payments: $956.12
Abinash Roy, Md, MD
Nephrology — Payments: $641.61
Christof Westenfelder, Md, MD
Nephrology — Payments: $386.59